Viveon Health Acquisition Corp.
VHAQ · AMEX
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 1.91 | -0.64 | 0.00 |
| FCF Yield | -1.35% | -1.03% | 1.10% |
| EV / EBITDA | 68.99 | -49.26 | -123.52 |
| Quality | |||
| ROIC | -13.88% | -2.04% | -0.22% |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 3.60 | -0.84 | -0.29 |
| Growth | |||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 15.80% | -424.20% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 2.08 | 0.10 | 6.37 |
| Interest Coverage | -0.65 | 0.00 | 0.00 |
| Efficiency | |||
| Inventory Turnover | 0.00 | -55.67 | 0.00 |
| Cash Conversion Cycle | -109.44 | -23.15 | 0.00 |